Patent AT-E400274-T1: [Translated] ACT ACTIVITY INHIBITORS
Description
The present invention is directed to compounds comprising a 2,3-diphenylquinoxaline moiety which inhibit the activity of Akt, a serine/threonine protein kinase. The invention is further directed to chemotherapeutic compositions containing the compounds of this invention and methods for treating cancer comprising administration of the compounds of the invention
Resources
| Name |
Format |
Description |
Link |
|
21 |
Access the complete Patent AT-E400274-T1: [Translated] ACT ACTIVITY INHIBITORS on the official website. |
https://pubchem.ncbi.nlm.nih.gov/patent/AT-E400274-T1 |
Tags
- patent
- chemistry
- research
- innovation
- pubchem